Article

Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma

2022-11-14

Abstract excerpt

<title>Abstract</title><p>Bladder cancer is a major and fatal urological disease. Cisplatin is a key drug for the treatment of bladder cancer, especially in muscle-invasive cases. In most cases of bladder cancer, cisplatin is effective; however, resistance to cisplatin has a significant negative impact on prognosis. Thus, a treatment strategy for cisplatin-resistant bladder cancer is essential to improve the progn...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f57e8e96-98f2-545d-8a1c-ba41a9075ba4
DOI: 10.21203/rs.3.rs-2259361/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinomaDOI 10.21203/rs.3.rs-2259361/v1Read

Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing.Semantic proximity Read

Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell linesSemantic proximity Read

Doctors revise Declaration of HelsinkiSemantic proximity Read

FOLLOW-U; study protocol evaluating oncological systemic treatment response of advanced bladder cancer patients using urinoidsSemantic proximity Read

NPEPPS is a novel and druggable driver of platinum resistanceSemantic proximity Read

Resistance to Platinum-Based Chemotherapy in Muscle-Invasive Bladder Cancer: Genetic and Immune Determinants and Implications for Treatment Sequencing — A Case SeriesSemantic proximity Read

Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancerSemantic proximity Read

Low MSH2 protein levels identify muscle-invasive bladder cancer resistant to cisplatinSemantic proximity Read

lncRNA TINCR SNPs and Expression Levels Are Associated with Bladder Cancer Susceptibility.Semantic proximity Read

Adseverin: A novel cisplatin‐resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysisSemantic proximity Read

Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancerSemantic proximity Read

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.Semantic proximity Read